Status:
COMPLETED
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Conditions:
Dysphagia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their eso...
Detailed Description
This is a randomized two-arms cross-over trial. In this study there are two groups, the control group and the triamcinolone treatment group. The cross-over design will apply only in the control group ...
Eligibility Criteria
Inclusion
- Patients who present for EGD with dilation for dysphagia symptoms thought secondary to either radiation-induced stricture or anastomotic stricture based on history
Exclusion
- Inability to consent for the procedure
- Known coagulopathy \[International Normalized Ratio (INR) \>1.5, Platelets \<75 K\]
- Endoscopic finding of a stricture that is not caused by either radiation or anastomotic narrowing
- Nasopharyngeal strictures
Key Trial Info
Start Date :
July 18 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 16 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01873573
Start Date
July 18 2013
End Date
October 16 2017
Last Update
October 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States, 33612